Insulin‑Aspart‑Szjj 100 units/mL Suppliers & Bulk Manufacturers
Available Forms: SQ Injection
Available Strengths: 100 units/mL
Reference Brands: NovoLog; Merilog is biosimilar to NovoLog.
Category: Biosimilars
Merilog, a biosimilar to NovoLog (insulin aspart), mimics natural insulin by stimulating glucose uptake in tissues, reducing blood sugar levels. It provides rapid, consistent blood glucose control, supports flexible dosing, and offers similar efficacy, safety, and benefits as the original, supporting effective diabetes management when used under medical supervision.
Product Description:
Merilog is regulated as a biosimilar to NovoLog (insulin aspart) in both the EU and US. In the US, FDA approval involves extensive comparability, safety, and efficacy data in accordance with GMP standards. In the EU, CE marking certifies conformity with MDR standards for biosimilarity, validated through dossiers demonstrating biosimilarity, safety, efficacy, and manufacturing quality. These biosimilars undergo validation, stability testing, and audits, supported by comprehensive documentation including clinical data, safety profiles, and manufacturing practices. For licensing procedures, approved dossiers, and regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to affordable, high-quality insulin biosimilars supporting optimal diabetes management worldwide.
Insulin‑Aspart‑Szjj — third party manufacturing & bulk supply
Insulin‑Aspart‑Szjj 100 units/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Insulin‑Aspart‑Szjj listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Insulin‑Aspart‑Szjj →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Eculizumab‑Aeeb
Strength:
300 mg/20 mL (IV infusion),
Form: Injection for intravenous infusion
Reference Brands: Soliris, Bkemv- Biosimilar of Soliris, Epysqli- Biosimilar of Soliris
View Details
Omalizumab‑Igec
Strength:
75 mg/0.5 mL and 150 mg/mL
Form: Pre filled syringe
Reference Brands: Xolair, Omlyclo - a Biosimilar to Xolair
View Details
Tocilizumab-Bavi
Strength:
80 mg/4ml
Form: Intravenous infusion
Reference Brands: Actemra; Tofidence - biosimilar to Actemra (tocilizumab).
View Details
Denosumab(Others Approved)
Strength:
60 mg, 120 mg
Form: Subcutaneous injection
Reference Brands: Xgeva(US & EU) Ospomyv, Xbryk, Merilog, Stoboclo, Zadenvi, Enwylma, Denbrayce, Izamby - biosimilar to Xgeva
View DetailsQuick Response Guaranteed | Verified Suppliers
